Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo.

Saunders LR, Bankovich AJ, Anderson WC, Aujay MA, Bheddah S, Black K, Desai R, Escarpe PA, Hampl J, Laysang A, Liu D, Lopez-Molina J, Milton M, Park A, Pysz MA, Shao H, Slingerland B, Torgov M, Williams SA, Foord O, Howard P, Jassem J, Badzio A, Czapiewski P, Harpole DH, Dowlati A, Massion PP, Travis WD, Pietanza MC, Poirier JT, Rudin CM, Stull RA, Dylla SJ.

Sci Transl Med. 2015 Aug 26;7(302):302ra136. doi: 10.1126/scitranslmed.aac9459.

2.

Antitumor therapy mediated by 5-fluorocytosine and a recombinant fusion protein containing TSG-6 hyaluronan binding domain and yeast cytosine deaminase.

Park JI, Cao L, Platt VM, Huang Z, Stull RA, Dy EE, Sperinde JJ, Yokoyama JS, Szoka FC.

Mol Pharm. 2009 May-Jun;6(3):801-12. doi: 10.1021/mp800013c.

3.

Expression analysis of secreted and cell surface genes of five transformed human cell lines and derivative xenograft tumors.

Stull RA, Tavassoli R, Kennedy S, Osborn S, Harte R, Lu Y, Napier C, Abo A, Chin DJ.

BMC Genomics. 2005 Apr 18;6:55.

5.

An in vitro messenger RNA binding assay as a tool for identifying hybridization-competent antisense oligonucleotides.

Stull RA, Zon G, Szoka FC Jr.

Antisense Nucleic Acid Drug Dev. 1996 Fall;6(3):221-8.

PMID:
8915507
6.

Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Stull RA, Szoka FC Jr.

Pharm Res. 1995 Apr;12(4):465-83. Review.

PMID:
7596980
8.
9.

PLANNING: VITAL FUNCTION OF ADMINISTRATIVE NURSES.

STULL RA.

Hosp Top. 1965 Feb;43:46-9. No abstract available.

PMID:
14257498

Supplemental Content

Loading ...
Support Center